Effect of TachoSil on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Bladder cancer; Prostate cancer
- Focus Pharmacodynamics
- 24 Aug 2017 Status changed from recruiting to completed.
- 08 Apr 2016 Planned End Date changed from 1 Oct 2015 to 1 Oct 2016, as reported by ClinicalTrials.gov.
- 08 Apr 2016 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2016, as reported by ClinicalTrials.gov.